Aptose Biosciences
APTO
#10464
Rank
NZ$7.56 M
Marketcap
NZ$2.96
Share price
0.00%
Change (1 day)
764.89%
Change (1 year)

Aptose Biosciences (APTO) - Net assets

Net assets on the balance sheet as of March 2025 : -NZ$12.81 Million

According to Aptose Biosciences's latest financial reports the company has -NZ$12.81 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Aptose Biosciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2023-12-31$-NZ$4.59 Million-107.72%
2022-12-31$NZ$59.44 M-45.31%
2021-12-31$NZ$0.10 B-34.05%
2020-12-31$NZ$0.16 B18.17%
2019-12-31$NZ$0.13 B564.36%
2018-12-31$NZ$20.99 M46.14%
2017-12-31$NZ$14.36 M35.79%
2016-12-31$NZ$10.57 M-46.96%
2015-12-31$NZ$19.94 M
2014-05-31$NZ$30.85 M-3391.35%
2013-05-31$-NZ$0.94 Million-64.1%
2012-05-31$-NZ$2.62 Million-981.13%
2011-05-31$NZ$0.29 M-139.07%
2010-05-31$-NZ$0.76 Million-93.58%
2009-05-31$-NZ$11.81 Million138.88%
2008-05-31$-NZ$4.95 Million-617.15%
2007-05-31$NZ$0.95 M-125.88%
2006-05-31$-NZ$3.7 Million-124.53%
2005-05-31$NZ$15.06 M-54.84%
2004-05-31$NZ$33.35 M-8.54%
2003-05-31$NZ$36.46 M-40.05%
2002-05-31$NZ$60.82 M-30.31%
2001-05-31$NZ$87.28 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Advaxis
ADXS
-NZ$42.31 Million 230.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
NZ$0.19 B-1,601.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
NZ$0.97 B-7,696.32%๐Ÿ‡บ๐Ÿ‡ธ USA